Back to Search Start Over

Cerium oxide nanoparticles reestablish cell integrity checkpoints and apoptosis competence in irradiated HaCaT cells via novel redox-independent activity

Authors :
Fanny Caputo
Anna Giovanetti
Francesca Corsi
Vittoria Maresca
Stefania Briganti
Silvia Licoccia
Enrico Traversa
Lina Ghibelli
Giovanetti, A.
Source :
Frontiers in Pharmacology, Frontiers in Pharmacology, Vol 9 (2018)
Publication Year :
2018
Publisher :
Frontiers Media S.A., 2018.

Abstract

Cerium oxide nanoparticles (CNPs) are potent radical scavengers protecting cells from oxidative insults, including ionizing radiation. Here we show that CNPs prevent X-ray-induced oxidative imbalance reducing DNA breaks on HaCat keratinocytes, nearly abating mutagenesis. At the same time, and in spite of the reduced damage, CNPs strengthen radiation-induced cell cycle arrest and apoptosis outcome, dropping colony formation; notably, CNPs do not possess any intrinsic toxicity toward non-irradiated HaCat, indicating that they act on damaged cells. Thus CNPs, while exerting their antioxidant action, also reinforce the stringency of damage-induced cell integrity checkpoints, promoting elimination of the “tolerant” cells, being in fact radio-sensitizers. These two contrasting pathways are mediated by different activities of CNPs: indeed Sm-doped CNPs, which lack the Ce3+/Ce4+ redox switch and the correlated antioxidant action, fail to decrease radiation-induced superoxide formation, as expected, but surprisingly maintain the radio-sensitizing ability and the dramatic decrease of mutagenesis. The latter is thus attributable to elimination of damaged cells rather than decreased oxidative damage. This highlights a novel redox-independent activity of CNPs, allowing selectively eliminating heavily damaged cells through non-toxic mechanisms, rather reactivating endogenous anticancer pathways in transformed cells. Copyright © 2018 Caputo, Giovanetti, Corsi, Maresca, Briganti, Licoccia, Traversa and Ghibelli.

Details

Language :
English
Database :
OpenAIRE
Journal :
Frontiers in Pharmacology, Frontiers in Pharmacology, Vol 9 (2018)
Accession number :
edsair.doi.dedup.....35f219104725050f5fcb321bbd1dcb1a